We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.

Vasomotor · Sleep

Menopause night sweats: treatments that actually work

Night sweats do more damage than hot flashes. They fragment sleep, spike cortisol at 3 AM, and cascade into brain fog, mood issues, and weight gain. The good news: they're one of the most treatable menopause symptoms — often the fastest to respond.

Why they wreck sleep

Each night sweat wakes you slightly (sometimes just enough to disrupt sleep architecture without conscious awakening). Cortisol rises, adenosine clears, and you spend the next day in low-grade sleep debt. This drives the "everything gets worse" cascade of menopause.

Treatment ladder

  1. Transdermal estradiol — most effective, cheapest, best safety data
  2. Fezolinetant (Veozah) — non-hormonal, effective, expensive
  3. SNRIs (venlafaxine, desvenlafaxine) — dual purpose for mood
  4. Gabapentin at bedtime — helps sweats and sleep
  5. Cognitive behavioral therapy for insomnia (CBT-I) — adjunct
  6. Environmental controls: cool room, breathable bedding, chill pillow

Frequently asked questions

What causes menopause night sweats?

Estrogen decline narrows the hypothalamic thermoneutral zone. Small overnight body temperature rises trigger sweating designed to cool you down — much larger than needed.

HRT vs fezolinetant for night sweats?

HRT is more effective (70–80% reduction) and cheaper. Fezolinetant (Veozah) is non-hormonal and works for women who can't take HRT — 50–65% reduction.

Do SSRIs help night sweats?

Yes. Low-dose paroxetine (Brisdelle), venlafaxine, and escitalopram all reduce vasomotor symptoms by 40–60%.

What about gabapentin?

Gabapentin 300–900mg at bedtime reduces night sweats and improves sleep. Useful when HRT is contraindicated.

When will they stop on their own?

Average duration is 7.4 years, but some women have vasomotor symptoms into their 60s and 70s. Not a "wait it out" situation.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.

Ask Dot